Legal cannabis businesses are urging Texas politicians and legislators to regulate the state’s CBD market.
Texas politicians and legislators are receiving calls to regulate their state’s cannabidiol (CBD) market. Nico Richardson, who is the CEO of Texas Original, one of the largest legal medical cannabis dispensaries in Texas, is urging Governor Greg Abbott and other state legislators to oversee the transactions of hemp-derived CBD products (1). This also would include Delta-8 and Delta-9 tetrahydrocannabinol (THC). Richardson (1) has commented on the matter and said that “the state's unregulated hemp market has created a public health crisis, citing a spike in drug-related offenses in Texas schools and the abundance of young patients involved in calls to the Texas Poison Center Network.”
In the Lone Star State, they have a small-scale Compassionate Use program (2). The program was created to allow doctors who have been approved to “legally prescribe low-levels of THC” (1) for health conditions such as, post-traumatic stress disorder (PTSD), epilepsy, and cancer. It is intensely regulated which has caused concern in other areas cannabis merchandise is sold and not kept a closer eye on.
Despite having this intensely regulated program, throughout the state, a consumer can purchase unregulated CBD products or CBD-derived THC products lie Delta-8 and Delta-9 from gas stations and vape enterprises (1).
Axios Dallas (1) reported that the “federal Food and Drug Administration has warned that some manufacturers may use unsafe chemicals to convert CBD into Delta-8 — and that children might be particularly vulnerable to the effects.” According to the National Cannabis Industry Association (1,3), Delta-8 is banned in 17 states throughout the US. Results from a September 2023 lawsuit have kept Delta-8 THC legal in the state of Texas (1,4).
The Texas Original CEO has further commented on the harms of Texas’s unregulated cannabis market by explaining how “third-party testing has demonstrated that hemp flower products in Texas being sold to minors test well above the legal limit for THC and include potentially harmful pesticides and microbial contaminants,” (1).
“It is long past time for our governor and state Legislature to work together to create a safe and effective regulatory framework for hemp products,” Richardson expressed to Axios (1). “If the Texas Legislature wants to legalize recreational marijuana, they should pass legislation to that effect and develop a regulatory framework to keep these products from kids. What they shouldn't do is turn a blind eye to an unregulated marijuana market that lacks crucial age minimums and consumer protections that exist in other states.”
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.